Mesa (Pharmaceutical Development) is Biotechnology in United States that focus on drug development business. Founded in 2011. They cover business area such as provider, pharmaceutical development service, drug delivery development, clinical study design, operation, formulation service, pre-clinical service, their client, their pharmaceutical development process.
2011
( 13 years old in 2024 )
Drug Development
-
4539 Metropolitan Court
Suite 207
Frederick, MD 21701
United States
Private
providerpharmaceutical development servicedrug delivery developmentclinical study designoperationformulation servicepre-clinical servicetheir clienttheir pharmaceutical development process
* We use standard office opening hours in near Mesa (Pharmaceutical Development)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Mesa (Pharmaceutical Development) is Biotechnology business from United States that founded in 2011 (13 years old in 2024), Mesa (Pharmaceutical Development) business is focusing on Drug Development.
Mesa (Pharmaceutical Development) headquarter office and corporate office address is located in 4539 Metropolitan Court Suite 207 Frederick, MD 21701 United States.
Mesa (Pharmaceutical Development) was founded in United States.
In 2024, Mesa (Pharmaceutical Development) is currently focus on drug development sector.
Above is snippet of Google Trends for "drug development" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Mesa (Pharmaceutical Development), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
